Skip to main content
. Author manuscript; available in PMC: 2015 Oct 23.
Published in final edited form as: AIDS. 2014 Oct 23;28(16):2461–2473. doi: 10.1097/QAD.0000000000000456
Unweighted models –
baseline covariates
Unweighted models –
baseline covariates and
time-varying covariates
Weighted models –
baseline covariates
Tuberculosis 0.77 (0.65,0.91) 0.95 (0.80,1.12) 0.48 (0.36,0.64)
MAC 1.12 (0.75,1.69) 1.25 (0.84,1.86) 0.51 (0.27,0.95)
CMV Retinitis 0.86 (0.52,1.42) 0.95 (0.58,1.54) 0.24 (0.09,0.66)
PML 1.04 (0.63,1.72) 1.03 (0.63,1.67) 0.41 (0.15,1.09)
Herpes Simplex Infection 0.97 (0.78,1.19) 1.09 (0.88,1.34) 0.76 (0.58,1.00)
Kaposi Sarcoma 0.53 (0.44,0.64) 0.84 (0.70,1.02) 0.22 (0.15,0.32)
Non Hodgkin Lymphoma 0.88 (0.69,1.11) 0.94 (0.74,1.20) 0.51 (0.36,0.73)
Cryptococcosis 0.46 (0.30,0.70) 0.57 (0.38,0.87) 0.15 (0.05,0.42)
Candidiasis 0.43 (0.34,0.54) 0.73 (0.58,0.90) 0.18 (0.12,0.26)

cART Combined antiretroviral therapy; CMV cytomegalovirus; MAC Mycobacterium avium complex; PML Progressive multifocal leukoencephalopathy.